App-Based Mindfulness for Kidney Cancer
Trial Summary
Will I have to stop taking my current medications?
The trial protocol does not specify whether you need to stop taking your current medications. However, since the trial involves mindfulness and not a new drug, it's likely you can continue your current treatments.
What data supports the effectiveness of the treatment App-Based Mindfulness Intervention for kidney cancer?
Is app-based mindfulness safe for cancer patients?
How is the App-Based Mindfulness Intervention treatment different from other treatments for kidney cancer?
What is the purpose of this trial?
This trial tests the feasibility of an application (app)-based mindfulness intervention and its effect on improving quality of life in patients with renal cell cancer that has spread to other places in the body (metastatic). This trial aims to see whether an app-based mindfulness intervention may help patients cope with their disease.
Research Team
Sumanta K Pal
Principal Investigator
City of Hope Medical Center
Eligibility Criteria
This trial is for patients with metastatic renal cell carcinoma who haven't practiced meditation regularly in the past year, have a significant fear of cancer progression, and have not been part of mindfulness-based recovery or stress reduction programs within 5 years. Participants must own a smartphone with internet access, be fluent in English, and currently be receiving immunotherapy.Inclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants engage in a mindfulness-based program using the Am app for 20-30 minutes every day, a minimum of 4 days each week over 4 weeks
Follow-up
Participants are monitored for psychosocial outcomes, quality of life, and fatigue over a 3-month period
Treatment Details
Interventions
- App-Based Mindfulness Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
City of Hope Medical Center
Lead Sponsor
National Cancer Institute (NCI)
Collaborator